Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
MDRX Veradigm
17.370-0.110-0.63%
Close
02/08 16:00 ET
17.3700.0000.00%
Post Mkt Price 02/08 16:08 ET
High
17.555
Open
17.430
Turnover
26.51M
Low
17.325
Pre Close
17.480
Volume
1.52M
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Jopari Solutions and Veradigm Collaborate to Provide Electronic Claim & Attachment Solutions for Veradigm Payerpath™ Customers
CONCORD, Calif., Feb. 1, 2023 /PRNewswire/ -- Jopari Solutions, Inc., today announced their partnership with Veradigm, formerly known as Allscripts, to provide electronic medical claim and attachment solutions to
Teacher Retirement System of Texas Purchases 56,616 Shares of Veradigm Inc. (NASDAQ:MDRX)
Teacher Retirement System of Texas grew its position in Veradigm Inc. (NASDAQ:MDRX – Get Rating) by 270.0% in the third quarter, according to its most recent 13F filing with the Securities and Excha
Allscripts Price Target Raised to $18.50/Share From $17.00 by Piper Sandler
Allscripts Cut to Neutral From Overweight by Piper Sandler
Piper Sandler Downgrades Veradigm to Neutral, Raises Price Target to $18.5
Piper Sandler analyst Jessica Tassan downgrades Veradigm (NASDAQ:MDRX) from Overweight to Neutral and raises the price target from $17 to $18.5.
Veradigm Downgraded to Neutral From Overweight at Piper Sandler
There's Been No Shortage Of Growth Recently For Veradigm's (NASDAQ:MDRX) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then a
Veradigm Network EHR Data Is Now Available in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) Format
New delivery format for three integrated electronic health record (EHR) sources to provide delivery flexibility for Veradigm clients CHICAGO--(BUSINESS WIRE)--#healthIT--Veradigm (NASDAQ: MDRX) announ
Veradigm (NASDAQ:MDRX) Sees Unusually-High Trading Volume
Shares of Veradigm Inc. (NASDAQ:MDRX – Get Rating) saw unusually-high trading volume on Wednesday . Approximately 469,463 shares changed hands during trading, a decline of 62% from the previous sessi
Veradigm Inc. (NASDAQ:MDRX) Given Average Rating of "Moderate Buy" by Brokerages
Veradigm Inc. (NASDAQ:MDRX – Get Rating) has been assigned an average recommendation of "Moderate Buy" from the nine analysts that are presently covering the company, Marketbeat.com reports. One res
Company Overview
More
Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segments. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units. The firm solutions include All EMRs, All Population Health Management, Patient Engagement, and Precision Medicine. The company was founded in 1986 and is headquartered in Chicago, IL.
CEO： Mr. Richard J. Poulton
Market： NASDAQ
Listing Date： 07/23/1999
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet